PT951294E - Formulaoes cicatrizantes contendo fibronectina plasmetica humana - Google Patents

Formulaoes cicatrizantes contendo fibronectina plasmetica humana

Info

Publication number
PT951294E
PT951294E PT97951010T PT97951010T PT951294E PT 951294 E PT951294 E PT 951294E PT 97951010 T PT97951010 T PT 97951010T PT 97951010 T PT97951010 T PT 97951010T PT 951294 E PT951294 E PT 951294E
Authority
PT
Portugal
Prior art keywords
fibronectin
formulations containing
containing human
plasmetic
scaring
Prior art date
Application number
PT97951010T
Other languages
English (en)
Inventor
Andre Beaulieu
Robert Paquin
Original Assignee
Andre Beaulieu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andre Beaulieu filed Critical Andre Beaulieu
Publication of PT951294E publication Critical patent/PT951294E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/27Growth hormone [GH] (Somatotropin)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
PT97951010T 1996-12-17 1997-12-12 Formulaoes cicatrizantes contendo fibronectina plasmetica humana PT951294E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/767,868 US5821220A (en) 1995-06-07 1996-12-17 Method of producing concentrated non-buffered solutions of fibronectin

Publications (1)

Publication Number Publication Date
PT951294E true PT951294E (pt) 2003-10-31

Family

ID=25080820

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97951010T PT951294E (pt) 1996-12-17 1997-12-12 Formulaoes cicatrizantes contendo fibronectina plasmetica humana

Country Status (11)

Country Link
US (1) US5821220A (pt)
EP (1) EP0951294B1 (pt)
JP (1) JP2001510463A (pt)
AT (1) ATE245443T1 (pt)
AU (1) AU747209B2 (pt)
CA (1) CA2275193A1 (pt)
DE (1) DE69723725T2 (pt)
DK (1) DK0951294T3 (pt)
ES (1) ES2203827T3 (pt)
PT (1) PT951294E (pt)
WO (1) WO1998026797A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030105007A1 (en) * 1995-06-07 2003-06-05 Andre Beaulieu PDGF-betabeta and fibronectin combined in a solid wound dressing for the treatment of wounds
US6528483B2 (en) * 1995-06-07 2003-03-04 André Beaulieu Method of producing concentrated non-buffered solutions of fibronectin
US7112320B1 (en) * 1995-06-07 2006-09-26 Andre Beaulieu Solid wound healing formulations containing fibronectin
KR20010042402A (ko) * 1998-04-01 2001-05-25 로잘란드 앤 칼도르 피부 상처의 치료를 위한 프로테아제 억제제의 용도
DE10242320A1 (de) * 2002-09-12 2004-03-25 Thomas Steinmetz Golfspielanlage
GB0327046D0 (en) * 2003-11-20 2003-12-24 Queen Mary & Westfield College Regulation of sperm function
EP2729192B1 (en) 2011-07-05 2019-01-02 The Research Foundation for The State University of New York Compositions and methods for spinal disc repair and other surgical and non-surgical indications
WO2017037655A1 (en) * 2015-09-04 2017-03-09 Remedor Biomed Ltd. Topical erythropoietin formulations and methods for improving wound healing with and cosmetic use of the formulations
CN109568652A (zh) * 2018-12-26 2019-04-05 粤肽生物科技(珠海)有限公司 促进伤口快速愈合的敷料组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341764A (en) * 1980-03-05 1982-07-27 Cutter Laboratories, Inc. Method of preparing fibronectin and antihemophilic factor
JPS61103836A (ja) * 1984-10-24 1986-05-22 Green Cross Corp:The フイブロネクチン製剤
US4837019A (en) * 1986-08-11 1989-06-06 Charles Of The Ritz Group Ltd. Skin treatment composition and method for treating burned skin
US4857506A (en) * 1987-01-12 1989-08-15 American Cyanamid Company Sustained release growth hormone compositions for parenteral administration and their use
US5641483A (en) * 1995-06-07 1997-06-24 Beaulieu; Andre Wound healing formulations containing human plasma fibronectin

Also Published As

Publication number Publication date
ES2203827T3 (es) 2004-04-16
DE69723725T2 (de) 2004-04-22
EP0951294A1 (en) 1999-10-27
AU747209B2 (en) 2002-05-09
AU5470998A (en) 1998-07-15
US5821220A (en) 1998-10-13
DK0951294T3 (da) 2003-11-17
EP0951294B1 (en) 2003-07-23
ATE245443T1 (de) 2003-08-15
DE69723725D1 (de) 2003-08-28
CA2275193A1 (en) 1998-06-25
JP2001510463A (ja) 2001-07-31
WO1998026797A1 (en) 1998-06-25

Similar Documents

Publication Publication Date Title
PT784481E (pt) Formulacoes para cicatrizacao de feridas contendo fibronectina do plasma humano
ATE512650T1 (de) Hydrogelwundverband und zugehöriges herstellungs- und benutzungsverfahren
PT859596E (pt) Formulacoes em gel contendo factores de crescimento
DE60138549D1 (de) Topische gel-abgabesysteme zur behandlung von hauterkrankungen
ES2187665T3 (es) Uso de la il-10 para curar heridas con una cicatrizacion reducida.
ATE371457T1 (de) Verwendung von antimykotica zur topischen behandlung von pilz-induzierten schleimhautentzündungen
DK0923378T3 (da) Fremme af sårheling ved kemisk modificerede tetracykliner
ES2175295T3 (es) Uso de un poliholosido en una composicion destinada a favorecer la descamcion de la piel y su composicion.
PT951294E (pt) Formulaoes cicatrizantes contendo fibronectina plasmetica humana
ES2063250T3 (es) Uso de la trombospondina para facilitar la curacion de las heridas.
ATE255426T1 (de) Dermales hüllgewebe in der wundheilung
NZ330401A (en) Retinoic acid inhibitors such as rar antagonists for healing skin wounds
DE69716460D1 (de) Wundheilung und behandlung von fibrose
NO981866D0 (no) Terapeutisk anvendelse av hemoglobin for Õ fremme sÕrheling
NO934317D0 (no) Anvendelse av visse metanbisfosfonsyrederivater i brudd-heling
ATA4993A (de) Topische zusammensetzung zur beschleunigung der wundheilung
BR0109896A (pt) Composição tópica em gel, curativo de feridas, seu método e uso
IL138709A0 (en) METHODS FOR PROMOTING THE HEALING OF CUTANEOUS WOUNDS AND ULCERS USING COMPOSITIONS OF α-D-GLUCANS
PT1115375E (pt) Utilizacao de pelo menos um derivado do acido 10-hidroxi-2-decenoico numa composicao destinada a favorecer a descamacao da pele
AU5986498A (en) Use of aminothiazoles for treating wounds and skin
ITPD920102A1 (it) Composizione farmaceutica utile per trattare malattie gastroenteriche, ferite e ustioni e come agente emostatico
IT1125491B (it) Preparato per il trattamento di ferite,piaghe,ulcerazioni ed altre affezioni cutanee essudative
IL122359A0 (en) Stable gel formulation for topical treatment of skin conditions